Event-Driven Stocks

Comera Life Sciences Holdings, Inc.

CMRA

Healthcare · Healthcare · <br>Emerging growth company · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs3 good4 warning2 severedetails ↓

Financials

SEC XBRL · annual
 FY22FY21
Revenue$633,102$319,832
Operating income−$12.0M−$5.5M
Net income−$18.0M−$5.5M
Total assets$3.7M$7.4M
Total liabilities$5.5M$1.2M
Equity−$6.2M−$14.7M
EPS (diluted)$-1.76$-1.81
Shares out.16.7M308,443

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2022
Operating margin
−1890.7%
Net margin
−2843.8%
Return on equity
288.2%
Return on assets
−483.1%
Return on capital (ROCE)
Liabilities / assets
146.4%
Debt / equity
Book value / share
$-0.37
Revenue growth (YoY)
97.9%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2022
Altman Z″ (distress)
-56.83distress
Accruals / assets
220.9%clean
Piotroski F-Score
2/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
52
/ 100
Profitability 25Growth 100Catalyst 67Earnings quality 67Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

2 severe4 warning3 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Revenue is growing year-over-year
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Insider transactions

SEC Form 4 · most recent
2 acquisitions0 disposals1 open-market buy(s)net +13,113 shares · last 2
InsiderDateTypeSharesPrice
Campbell Michael GerardOfficer — EVP &amp; CFONov 27, 2023Buy10,000$0.07
Wexler William A.DirectorNov 15, 2023J3,113$0.00

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20264,35211.70.0%
Apr 30, 20264,35222.10.0%
Apr 15, 20264,3521000.00.0%
Mar 31, 20264,3521000.00.0%
Mar 13, 20264,3521000.00.0%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.